In hepatic fibrosis animal models, estradiol treatment markedly suppressed early apoptosis and hepatic fibrosis, reduced collagen content and α-SMA expression, and induced Bcl-2 expression [45,46,47]. The gene discussed is ACTA1; the disease is Hepatic fibrosis.